Cancer and Oncology Video Sharing Community

Spotlight
Video

This Week's Most Viewed Videos

Lurbinectedin More Pronounced in Overall Survival | OS Endpoint is Preferable from Regulatory POV

01:03

Lurbinectedin More Pronounced in Overall...

by: Annual-Meeting | 129 views

My Top 5 ASCO 2018 Abstracts in Stage I-III NSCLC, Small Cell Lung Cancer, & Mesothelioma (BMIC-037)

07:12

My Top 5 ASCO 2018 Abstracts in Stage I-...

by: BeaconMedIC | 350 views

My Top 5 ASCO 2018 Abstracts in Advanced NSCLC (BMIC-036)

10:17

My Top 5 ASCO 2018 Abstracts in Advanced...

by: BeaconMedIC | 400 views

Submitting Update of Monotherapy to ESMO | Closure of ATLANTIS Trial in Small Cell

00:50

Submitting Update of Monotherapy to ESMO...

by: Annual-Meeting | 74 views

Urology: Week’s Most Viewed Videos (more)

A 6-factor prognostic model for urothelial carcinoma patients receiving atezolizumab

02:53

A 6-factor prognostic model for urotheli...

by: VJOncology | 40 views

Could cabozantinib be a successful novel therapy for mCRPC?

01:28

Could cabozantinib be a successful novel...

by: VJOncology | 34 views

AUA 2010 interview of Dr. Tom Lue, MD professor of Urology at UCSF talks about Peyronie's disease

05:51

AUA 2010 interview of Dr. Tom Lue, MD pr...

by: imedex | 11144 views

Bevacizumab in combination with chemotherapy in metastatic urothelial cancer

00:59

Bevacizumab in combination with chemothe...

by: AnnualMeeting2016 | 333 views

Kidney Cancer: Week’s Most Viewed Videos (more)

Immunotherapy: The Role of the Microbiome

14:26

Immunotherapy: The Role of the Microbio...

by: kidneycancer | 99 views

Kidney Cancer Experts at UT Southwestern discuss the CARMENA trial

19:50

Kidney Cancer Experts at UT Southwestern...

by: University of Texas Southwes... | 29 views

A Patient View

10:51

A Patient View

by: kidneycancer | 94 views

Treatment after immune checkpoint in first/second line setting: Clinical perspective

15:21

Treatment after immune checkpoint in fir...

by: kidneycancer | 84 views

Hodgkin Lymphoma: Week’s Most Viewed Videos (more)

ECHELON-1 trial data from ASH 2017: controversies and clinical translation

03:08

ECHELON-1 trial data from ASH 2017: cont...

by: VJHemOnc | 189 views

Phase 2 trial of brentuximab vedotin plus AVD for limited-stage Hodgkin lymphoma | Dr Jeremy Abramson at Annual Meeting 2015

03:26

Phase 2 trial of brentuximab vedotin plu...

by: EMJ | 645 views

Results of the Echelon-1 Trial New chemotherapy is a combination of brentuximab vedotin, and AVD

00:47

Results of the Echelon-1 Trial New chemo...

by: ASHReport | 93 views

How should we approach the adolescent/young adult Hodgkin lymphoma patient?

22:56

How should we approach the adolescent/yo...

by: imedex | 651 views